We are live on ! Find out more
JF

Jump Financial Portfolio holdings

AUM $7.5B
1-Year Est. Return 33.9%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
AUM
$3.71B
AUM Growth
+$566M
Cap. Flow
+$363M
Cap. Flow %
9.8%
Top 10 Hldgs %
18.4%
Holding
2,426
New
695
Increased
612
Reduced
544
Closed
571

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 11.18%
3 Industrials 10.29%
4 Healthcare 10.12%
5 Consumer Discretionary 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTV
1801
DELISTED
Innovid Corp.
CTV
$88.9K ﹤0.01%
+35,699
New +$61.8K
WRAP icon
1802
Wrap Technologies
WRAP
$103M
$87.8K ﹤0.01%
+38,865
New +$131K
ADTH
1803
DELISTED
AdTheorent Holding Co
ADTH
$85.6K ﹤0.01%
+26,674
New +$73K
RLAY icon
1804
Relay Therapeutics
RLAY
$4.1B
$85.6K ﹤0.01%
+10,316
New +$101K
LCID icon
1805
Lucid Motors
LCID
$2.88B
$85.3K ﹤0.01%
+2,994
New +$95.5K
RLGT icon
1806
Radiant Logistics
RLGT
$386M
$84.8K ﹤0.01%
15,654
+277
+2% +$1.64K
CTMX icon
1807
CytomX Therapeutics
CTMX
$675M
$84.1K ﹤0.01%
+38,578
New +$71.2K
AXTI icon
1808
AXT Inc
AXTI
$3.95B
$83.9K ﹤0.01%
+18,286
New +$62.1K
TCRX icon
1809
TScan Therapeutics
TCRX
$48.6M
$81.7K ﹤0.01%
+10,291
New +$64.7K
WNEB icon
1810
Western New England Bancorp
WNEB
$259M
$80.5K ﹤0.01%
+10,497
New +$87.2K
AKBA icon
1811
Akebia Therapeutics
AKBA
$354M
$76.7K ﹤0.01%
+41,920
New +$67K
EGAN icon
1812
eGain
EGAN
$187M
$74.2K ﹤0.01%
+11,500
New +$78.9K
VCSA
1813
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$74K ﹤0.01%
+10,852
New +$88.5K
IVVD icon
1814
Invivyd
IVVD
$158M
$73.7K ﹤0.01%
+16,589
New +$68.5K
MRSN
1815
DELISTED
Mersana Therapeutics
MRSN
$72.8K ﹤0.01%
+650
New +$64.6K
TTSH
1816
DELISTED
Tile Shop Holdings
TTSH
$72.4K ﹤0.01%
+10,300
New +$69.4K
PXLW icon
1817
Pixelworks
PXLW
$38.2M
$72.3K ﹤0.01%
+2,335
New +$61.9K
COGT icon
1818
Cogent Biosciences
COGT
$6.65B
$70.7K ﹤0.01%
10,525
-14,493
-58% -$89.6K
ALLO icon
1819
Allogene Therapeutics
ALLO
$649M
$63.9K ﹤0.01%
+14,298
New +$59.7K
TRVI icon
1820
Trevi Therapeutics
TRVI
$2.59B
$63.6K ﹤0.01%
+18,441
New +$41.1K
SAVE
1821
DELISTED
Spirit Airlines, Inc.
SAVE
$63.4K ﹤0.01%
+13,109
New +$96.9K
CRBU icon
1822
Caribou Biosciences
CRBU
$145M
$61.4K ﹤0.01%
+11,954
New +$73.7K
CBIO
1823
Crescent Biopharma
CBIO
$537M
$60.3K ﹤0.01%
+201
New +$60K
ZVRA icon
1824
Zevra Therapeutics
ZVRA
$562M
$59.3K ﹤0.01%
10,232
-22,968
-69% -$141K
RPTX
1825
DELISTED
Repare Therapeutics
RPTX
$58.9K ﹤0.01%
12,500
-27,103
-68% -$174K

Similar funds

Jump Financial's Q1 2024 Portfolio in Review

As of Q1 2024, Jump Financial held 2,426 positions worth $3.71B, up 18% from $3.14B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jump Financial deployed $363M of net new capital in Q1 2024, opening 695 new positions and adding to 612 existing holdings. Its largest new stake was ProShares Bitcoin Strategy ETF: 453,633 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $104M trimmed.

  • Jump Financial's largest Q1 2024 buy was ProShares Bitcoin Strategy ETF: 453,633 shares worth $14.7M.
  • Jump Financial added most to Invesco QQQ Trust in Q1 2024, an estimated $171M increase.
  • Jump Financial's biggest Q1 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $104M.
  • Jump Financial fully exited Vanguard S&P 500 ETF in Q1 2024, selling an estimated $55.9M.
  • Jump Financial's ten largest holdings make up 18% of its $3.71B portfolio in Q1 2024.
  • Jump Financial opened 695 new positions and closed 571 in Q1 2024.
  • Jump Financial's portfolio value rose 18% quarter-over-quarter to $3.71B.

Based on Jump Financial's 13F filing for Q1 2024, filed 13 May 2024.